Horizon 2020

With the support of €3.4m in European Research and shareholder matched funding, Irish biotech firm Ovagen Group Ltd has succeeded in producing a world-first product that can significantly boost the global production of vaccines.

With the support of €3.4m in European Research and shareholder matched funding, Irish biotech firm Ovagen Group Ltd has succeeded in producing a world-first product that can significantly boost the global production of vaccines.